(Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | (Q1)Aug 31, 2022 | (FY)May 31, 2022 | (Q4)May 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -21.34%20.69B | 4.22%23.76B | 0.77%20.26B | 22.17%90.94B | 9.09%21.74B | 32.94%26.3B | 29.12%22.8B | 17.78%20.1B | -12.49%74.43B | -6.77%19.93B |
Cost of revenue | -13.80%17.12B | 8.23%18.92B | 5.99%15.91B | 14.98%69.54B | 5.41%17.19B | 24.95%19.86B | 23.56%17.48B | 6.24%15.01B | -18.27%60.48B | -11.04%16.31B |
Gross profit | -44.59%3.57B | -8.99%4.84B | -14.58%4.35B | 53.34%21.4B | 25.71%4.54B | 65.62%6.44B | 51.58%5.32B | 73.10%5.1B | 26.25%13.95B | 19.04%3.61B |
Operating expense | -67.86%1.19B | -19.92%1.17B | -28.65%1.35B | 59.86%10.22B | 21.28%3.18B | 155.86%3.69B | 20.64%1.46B | 68.93%1.89B | 28.75%6.39B | 45.28%2.62B |
Staff costs | ---- | ---- | ---- | 1.39%802M | ---- | ---- | ---- | ---- | -1.62%791M | ---- |
Selling and administrative expenses | ---- | ---- | ---- | 36.24%1.14B | ---- | ---- | ---- | ---- | 26.28%836M | ---- |
-General and administrative expense | ---- | ---- | ---- | 36.24%1.14B | ---- | ---- | ---- | ---- | 26.28%836M | ---- |
Research and development costs | ---- | ---- | ---- | 98.87%6.53B | ---- | ---- | ---- | ---- | 43.30%3.28B | ---- |
Depreciation and amortization | ---- | ---- | ---- | 18.52%64M | ---- | ---- | ---- | ---- | 0.00%54M | ---- |
-Depreciation | ---- | ---- | ---- | 18.52%64M | ---- | ---- | ---- | ---- | 0.00%54M | ---- |
Other operating expenses | ---- | ---- | ---- | 17.88%1.68B | ---- | ---- | ---- | ---- | 23.78%1.43B | ---- |
Operating profit | -13.44%2.38B | -4.85%3.67B | -6.27%3B | 47.82%11.18B | 37.39%1.37B | 12.50%2.75B | 67.90%3.86B | 75.66%3.2B | 24.21%7.56B | -19.30%995M |
Net non-operating interest income (expenses) | -300.00%-2M | -3M | 0 | 0.00%1M | 0 | 0.00%1M | 0 | 0 | 0.00%1M | 0 |
Non-operating interest income | --0 | --0 | --0 | 0.00%1M | --0 | 0.00%1M | --0 | --0 | 0.00%1M | --0 |
Non-operating interest expense | --2M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --0 |
Net investment income | 0.00%3M | 56.76%-16M | -39.13%28M | -18.84%56M | 0.00%44M | -57.14%3M | -470.00%-37M | 475.00%46M | 392.86%69M | 780.00%44M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -18M | 0 | 16M | 0 | 0 | 0 | 0 | 0 | -16M | |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 236.36%75M | 48.00%-39M | 155.26%21M | -106.40%-258M | -83.67%-90M | -5,400.00%-55M | -5.63%-75M | -850.00%-38M | -34.41%-125M | -1,533.33%-49M |
Less:Other special charges | -236.36%-75M | -48.00%39M | -155.26%-21M | 222.50%258M | 83.67%90M | 5,400.00%55M | 188.46%75M | 850.00%38M | -13.98%80M | 1,533.33%49M |
Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --45M | --0 |
Other non-operating income (expenses) | 300.00%2M | -42.37%34M | 200.00%18M | 53.33%23M | -156.25%-41M | -111.11%-1M | 637.50%59M | -57.14%6M | -16.67%15M | 15.79%-16M |
Income before tax | -9.48%2.44B | -4.21%3.64B | -4.10%3.09B | 46.62%11B | 34.31%1.28B | 9.58%2.7B | 69.51%3.8B | 74.66%3.22B | 24.49%7.5B | -21.50%953M |
Income tax | -9.47%755M | -4.27%1.12B | -3.55%950M | 42.38%3.38B | 14.24%393M | 9.45%834M | 65.40%1.17B | 75.27%985M | 25.45%2.38B | -8.75%344M |
Net income | -9.49%1.69B | -4.18%2.52B | -4.34%2.14B | 48.61%7.62B | 45.89%887M | 9.57%1.87B | 71.47%2.63B | 74.45%2.23B | 24.03%5.13B | -27.36%608M |
Net income continuous operations | -9.49%1.69B | -4.18%2.52B | -4.34%2.14B | 48.59%7.62B | 45.65%887M | 9.64%1.87B | 71.40%2.63B | 74.40%2.23B | 24.05%5.13B | -27.24%609M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -9.49%1.69B | -4.18%2.52B | -4.34%2.14B | 48.61%7.62B | 45.89%887M | 9.57%1.87B | 71.47%2.63B | 74.45%2.23B | 24.03%5.13B | -27.36%608M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -9.49%1.69B | -4.18%2.52B | -4.34%2.14B | 48.61%7.62B | 45.89%887M | 9.57%1.87B | 71.47%2.63B | 74.45%2.23B | 24.03%5.13B | -27.36%608M |
Gross dividend payment | ||||||||||
Basic earnings per share | -9.52%52.56 | -4.17%78.51 | -4.33%66.51 | 48.61%237.16 | 45.75%27.62 | 9.62%58.09 | 71.44%81.93 | 74.41%69.52 | 24.02%159.59 | -27.31%18.95 |
Diluted earnings per share | -9.51%52.56 | -4.18%78.5068 | -4.33%66.51 | 48.61%237.16 | 45.89%27.6112 | 9.62%58.0863 | 71.47%81.93 | 74.41%69.52 | 24.02%159.59 | -27.36%18.9263 |
Dividend per share | 0 | 0.00%32 | 0 | 42.22%64 | 23.08%32 | 0 | 68.42%32 | 0 | 36.36%45 | 52.94%26 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
No Data